NEW YORK, June 21, 2023 /PRNewswire/ -- The bone biopsy market size is forecast to grow by USD 76.77 million between 2022 and 2027. The growth momentum will be accelerating at a CAGR of 7.74% during the forecast period. The market is driven by the rising prevalence of cancer. The prevalence of various types of cancer cases is increasing significantly worldwide. For instance, according to the American Cancer Society, about 3,970 new cases of cancer in bones and joints will be diagnosed in 2023. This is expected to increase the demand for biopsy among patients. Biopsy is non-invasive procedure. It detects the presence of various cancers more effectively using the individual blood sample. It helps oncologists select the appropriate treatment methods, including the type of surgery, radiotherapy, and drugs required for the treatment. Thus, with the increasing prevalence of cancer, the growth of the market will increase over the forecast period. For more insights on the historic data (2017 to 2021) and forecast market size (2023 to 2027) – Request a report sample
Regional Analysis
By region, the global bone biopsy market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 38% of market growth during the forecast period. The region has witnessed significant technology adoption in the healthcare sector over the past few years. In addition, factors such as increasing healthcare expenditure, rising prevalence of bone cancer, strong presence of vendors, and technological advances in biopsy techniques are driving the growth of the bone biopsy market in North America.
Market Dynamics
The growth of the market is driven by factors such as the growing number of diagnostic centers, the rising prevalence of cancer, and the increasing preference for minimally invasive biopsies. However, the risk of infections associated with the use of biopsy needles will challenge the growth of the market.
Company Profiles
The global bone biopsy market is fragmented. The market comprises many large and small-sized vendors. The vendors differentiate their products based on device quality, the accuracy of results, and associated value-added services. Some vendors are forming licensing agreements with other companies to increase product sales across the world, particularly in emerging countries such as India and China. In addition, they enter into partnerships with research institutions and diagnostic centers to develop innovative products to meet their medical needs.The bone biopsy market report includes information on the key products and recent developments of leading vendors, including:
- Becton Dickinson and Co. - The company offers FR 140 R bone biopsy trephine which is designed to examine cells from bone marrow.
- BIOPSYBELL Srl - The company offers bone biopsy needle which is designed for obtaining a sample of bones from body for laboratory testing.
- Cardinal Health Inc. - The company offers osteobell explant bone marrow harvest needles designed for allogeneic and autologous bone marrow harvest transplantation procedure.
- Cook Group Inc. - The company offers monoject, snarecoil, and monoject bone marrow biopsy needles which are designed for bone marrow procedures.
Why Buy?
- Add credibility to strategy
- Analyzes competitor's offerings
- Get a holistic view of the market
Grow your profit margin with Technavio – Buy the Report!
Competitive Analysis
The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample
Market Segmentation
- By type, the market is segmented into needle biopsy and open biopsy.
- By end-user, the market is segmented into hospitals and diagnostic centers.
- By geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW).
What are the key data covered in this bone biopsy market report?
- CAGR of the market during the forecast period.
- Detailed information on factors that will drive the growth of the market between 2023 and 2027
- Precise estimation of the size of the bone biopsy market and its contribution to the parent market.
- Accurate predictions about upcoming trends and changes in consumer behavior.
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW).
- A thorough analysis of the market's competitive landscape and detailed information about vendors.
- Comprehensive analysis of factors that will challenge the growth of bone biopsy market vendors.
Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights
Related Reports:
- The breast cancer liquid biopsy testing devices market size is expected to increase to USD 730.4 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 23.58%. The market is segmented by type (CTCs and circulating nucleic acids and extracellular vesicles) and geography (North America, Europe, Asia, and Rest of World (ROW)).
- The breast biopsy devices market is estimated to grow at a CAGR of 10.95% between 2022 and 2027. The size of the market is forecast to increase by USD 721.64 million. The market is segmented by product (biopsy needles and systems, biopsy image-guided systems, and others), end-user (hospitals, ASCS, breast cancer specialty centers and clinics, and others), modality (stereotactic x-ray guided breast biopsy, ultrasound-guided breast biopsy, and MRI-guided breast biopsy), and geography (North America, Europe, Asia, and Rest of World (ROW)).
Bone Biopsy Market Scope |
|
Report Coverage |
Details |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.74% |
Market growth 2023-2027 |
USD 76.77 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.92 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Germany, France, China, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Becton Dickinson and Co., BIOPSYBELL Srl, Cardinal Health Inc., Cook Group Inc., Kimal Group, Laurane Medical LLC, Meditech Devices Pvt. Ltd., Medtronic Plc, Merit Medical Systems Inc., Moller Medical GmbH, Remington Medical, SOMATEX Medical Technologies GmbH, Teleflex Inc., Tsunami Medical Srl, Zamar Care, B. Braun SE, and Stryker Corp. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global bone biopsy market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global bone biopsy market 2017 - 2021 ($ million)
- 4.2 Type Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
- 4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
- 6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
- 6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type
- 6.3 Needle biopsy - Market size and forecast 2022-2027
- Exhibit 34: Chart on Needle biopsy - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Needle biopsy - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Needle biopsy - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Needle biopsy - Year-over-year growth 2022-2027 (%)
- 6.4 Open biopsy - Market size and forecast 2022-2027
- Exhibit 38: Chart on Open biopsy - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Open biopsy - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Open biopsy - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Open biopsy - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ million)
- Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user
- 7.1 Market segments
- Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
- 7.2 Comparison by End-user
- Exhibit 46: Chart on Comparison by End-user
- Exhibit 47: Data Table on Comparison by End-user
- 7.3 Hospitals - Market size and forecast 2022-2027
- Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
- 7.4 Diagnostic centers - Market size and forecast 2022-2027
- Exhibit 52: Chart on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Diagnostic centers - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Diagnostic centers - Year-over-year growth 2022-2027 (%)
- 7.5 Market opportunity by End-user
- Exhibit 56: Market opportunity by End-user ($ million)
- Exhibit 57: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2022-2027 (%)
- Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 Germany - Market size and forecast 2022-2027
- Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.9 China - Market size and forecast 2022-2027
- Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.10 France - Market size and forecast 2022-2027
- Exhibit 91: Chart on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on France - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on France - Year-over-year growth 2022-2027 (%)
- 9.11 Japan - Market size and forecast 2022-2027
- Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 104: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 105: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification
- 12.3 B. Braun SE
- Exhibit 107: B. Braun SE - Overview
- Exhibit 108: B. Braun SE - Business segments
- Exhibit 109: B. Braun SE - Key news
- Exhibit 110: B. Braun SE - Key offerings
- Exhibit 111: B. Braun SE - Segment focus
- 12.4 Becton Dickinson and Co.
- Exhibit 112: Becton Dickinson and Co. - Overview
- Exhibit 113: Becton Dickinson and Co. - Business segments
- Exhibit 114: Becton Dickinson and Co. - Key news
- Exhibit 115: Becton Dickinson and Co. - Key offerings
- Exhibit 116: Becton Dickinson and Co. - Segment focus
- 12.5 BIOPSYBELL Srl
- Exhibit 117: BIOPSYBELL Srl - Overview
- Exhibit 118: BIOPSYBELL Srl - Product / Service
- Exhibit 119: BIOPSYBELL Srl - Key offerings
- 12.6 Cardinal Health Inc.
- Exhibit 120: Cardinal Health Inc. - Overview
- Exhibit 121: Cardinal Health Inc. - Business segments
- Exhibit 122: Cardinal Health Inc. - Key news
- Exhibit 123: Cardinal Health Inc. - Key offerings
- Exhibit 124: Cardinal Health Inc. - Segment focus
- 12.7 Cook Group Inc.
- Exhibit 125: Cook Group Inc. - Overview
- Exhibit 126: Cook Group Inc. - Product / Service
- Exhibit 127: Cook Group Inc. - Key offerings
- 12.8 Kimal Group
- Exhibit 128: Kimal Group - Overview
- Exhibit 129: Kimal Group - Product / Service
- Exhibit 130: Kimal Group - Key offerings
- 12.9 Laurane Medical LLC
- Exhibit 131: Laurane Medical LLC - Overview
- Exhibit 132: Laurane Medical LLC - Product / Service
- Exhibit 133: Laurane Medical LLC - Key offerings
- 12.10 Meditech Devices Pvt. Ltd.
- Exhibit 134: Meditech Devices Pvt. Ltd. - Overview
- Exhibit 135: Meditech Devices Pvt. Ltd. - Product / Service
- Exhibit 136: Meditech Devices Pvt. Ltd. - Key offerings
- 12.11 Medtronic Plc
- Exhibit 137: Medtronic Plc - Overview
- Exhibit 138: Medtronic Plc - Business segments
- Exhibit 139: Medtronic Plc - Key news
- Exhibit 140: Medtronic Plc - Key offerings
- Exhibit 141: Medtronic Plc - Segment focus
- 12.12 Merit Medical Systems Inc.
- Exhibit 142: Merit Medical Systems Inc. - Overview
- Exhibit 143: Merit Medical Systems Inc. - Business segments
- Exhibit 144: Merit Medical Systems Inc. - Key offerings
- Exhibit 145: Merit Medical Systems Inc. - Segment focus
- 12.13 Remington Medical
- Exhibit 146: Remington Medical - Overview
- Exhibit 147: Remington Medical - Product / Service
- Exhibit 148: Remington Medical - Key offerings
- 12.14 SOMATEX Medical Technologies GmbH
- Exhibit 149: SOMATEX Medical Technologies GmbH - Overview
- Exhibit 150: SOMATEX Medical Technologies GmbH - Product / Service
- Exhibit 151: SOMATEX Medical Technologies GmbH - Key offerings
- 12.15 Stryker Corp.
- Exhibit 152: Stryker Corp. - Overview
- Exhibit 153: Stryker Corp. - Business segments
- Exhibit 154: Stryker Corp. - Key news
- Exhibit 155: Stryker Corp. - Key offerings
- Exhibit 156: Stryker Corp. - Segment focus
- 12.16 Tsunami Medical Srl
- Exhibit 157: Tsunami Medical Srl - Overview
- Exhibit 158: Tsunami Medical Srl - Product / Service
- Exhibit 159: Tsunami Medical Srl - Key offerings
- 12.17 Zamar Care
- Exhibit 160: Zamar Care - Overview
- Exhibit 161: Zamar Care - Product / Service
- Exhibit 162: Zamar Care - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 163: Inclusions checklist
- Exhibit 164: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 165: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 166: Research methodology
- Exhibit 167: Validation techniques employed for market sizing
- Exhibit 168: Information sources
- 13.5 List of abbreviations
- Exhibit 169: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

Newsrooms &
Influencers

Digital Media
Outlets

Journalists
Opted In
Share this article